Jiangsu Lianhuan Pharmaceutical: Jiangsu Lianhuan Pharmaceutical's analysis report on the proposal for issuing stocks to specific targets through simplified procedures in 2024.

SZSI · Jul 23

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.